{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:58:15Z","timestamp":1795204695051,"version":"4.10.3"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Amniotic fluid embolism is a rare disease that induces fatal coagulopathy; however, due to its rarity, it has not yet been examined in detail. The strict diagnostic criteria by Clark for amniotic fluid embolism include severe coagulopathy complicated by cardiopulmonary insufficiency, whereas the Japanese criteria also include postpartum hemorrhage or Disseminated Intravascular Coagulation in clinical practice. Amniotic fluid embolism cases with preceding consumptive coagulopathy may exist and are potential clinical targets for earlier assessments and interventions among amniotic fluid embolism cases fulfilling the Japanese, but not Clark criteria. The present study was performed to compare coagulopathy in the earlier stage between the amniotic fluid embolism patients diagnosed by Clark criteria (Clark group, <jats:italic toggle=\"yes\">n<\/jats:italic> = 6), those by the Japanese criteria (Non-Clark group, <jats:italic toggle=\"yes\">n<\/jats:italic> = 10), and peripartum controls and identify optimal clinical markers for earlier assessments of amniotic fluid embolism-related consumptive coagulopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective case-control study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>A single university-based center. Our amniotic fluid embolism registry program has accumulated clinical information and blood samples since 2003.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>Amniotic fluid embolism patients in the Clark and Non-Clark groups between 2009 and 2017 and peripartum controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Clinical information was collected on hemoglobin levels, platelet counts, and coagulation- and fibrinolysis-related variables. Fibrinolytic parameters were also measured and compared among the three groups before blood transfusion. Fibrinogen levels in all patients in the Clark group and most in the Non-Clark group decreased earlier than hemoglobin levels, which was consistent with the high hemoglobin\/fibrinogen ratio and, thus, is a promising clinical marker for the earlier assessment of amniotic fluid embolism-related consumptive coagulopathy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Earlier evaluations of consumptive coagulopathy and hyperfibrinolysis using the hemoglobin\/fibrinogen ratio following preemptive treatment may reduce the occurrence or prevent the aggravation of severe coagulopathy in amniotic fluid embolism patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004665","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T21:06:04Z","timestamp":1602104764000},"page":"e1251-e1259","source":"Crossref","is-referenced-by-count":28,"title":["Consumptive Coagulopathy Involving Amniotic Fluid Embolism: The Importance of Earlier Assessments for Interventions in Critical Care"],"prefix":"10.1097","volume":"48","author":[{"given":"Tomoaki","family":"Oda","sequence":"first","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Tamura","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ide","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Itoh","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Horikoshi","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Narumi","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kohmura-Kobayashi","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Furuta-Isomura","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizuko","family":"Yaguchi","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Uchida","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunao","family":"Suzuki","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Itoh","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Kanayama","sequence":"additional","affiliation":[{"name":"All authors: Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/0002-9378(95)91474-9","article-title":"Amniotic fluid embolism: Analysis of the national registry.","volume":"172","author":"Clark","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00006254-199006000-00003","article-title":"New concepts of amniotic fluid embolism: A review.","volume":"45","author":"Clark","year":"1990","journal-title":"Obstet Gynecol Surv"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jog.12428","article-title":"Amniotic fluid embolism: Pathophysiology and new strategies for management.","volume":"40","author":"Kanayama","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R4-20230812","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/1471-0528.13300","article-title":"Incidence, risk factors, management and outcomes of amniotic-fluid embolism: A population-based cohort and nested case-control study.","volume":"123","author":"Fitzpatrick","year":"2016","journal-title":"BJOG"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"49.e1","DOI":"10.1016\/j.ajog.2007.11.061","article-title":"Incidence and risk factors of amniotic fluid embolisms: A population-based study on 3 million births in the United States.","volume":"199","author":"Abenhaim","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1471-0528.2012.03323.x","article-title":"Amniotic fluid embolism: Incidence, risk factors, and impact on perinatal outcome.","volume":"119","author":"Kramer","year":"2012","journal-title":"BJOG"},{"key":"R7-20230812","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12884-015-0792-9","article-title":"Amniotic fluid embolism: An Australian-New Zealand population-based study.","volume":"15","author":"McDonnell","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajog.2016.06.037","article-title":"Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.","volume":"215","author":"Clark","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20230812","first-page":"8458375","article-title":"Atypical amniotic fluid embolism managed with a novel therapeutic regimen.","volume":"2017","author":"Rezai","year":"2017","journal-title":"Case Rep Obstet Gynecol"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajog.2018.11.1099","article-title":"Evaluation of proposed criteria for research reporting of amniotic fluid embolism.","volume":"220","author":"Stafford","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/jog.12452","article-title":"Clinical characteristics of amniotic fluid embolism: An experience of 29 years.","volume":"40","author":"Yoneyama","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJM195507212530305","article-title":"Hemorrhagic states during pregnancy.","volume":"253","author":"Ratnoff","year":"1955","journal-title":"N Engl J Med"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/jog.13417","article-title":"Japanese clinical practice guide for critical obstetrical hemorrhage (2017 revision).","volume":"43","author":"Takeda","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIR.0000000000000300","article-title":"Cardiac arrest in pregnancy: A scientific statement from the American Heart Association.","volume":"132","author":"Jeejeebhoy","year":"2015","journal-title":"Circulation"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/jog.12426","article-title":"Obstetrical disseminated intravascular coagulation score.","volume":"40","author":"Kobayashi","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1447-0756.1987.tb00001.x","article-title":"A prospective study in 38 patients with abruptio placentae of 70 cases complicated by DIC.","volume":"13","author":"Terao","year":"1987","journal-title":"Asia Oceania J Obstet Gynaecol"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/cc12783","article-title":"A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis.","volume":"17","author":"Gando","year":"2013","journal-title":"Crit Care"},{"key":"R18-20230812","first-page":"243","article-title":"Poor predictive value of hematocrit and hemodynamic parameters for erythrocyte deficits after extensive elective vascular operations.","volume":"175","author":"Cordts","year":"1992","journal-title":"Surg Gynecol Obstet"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"e0220740","DOI":"10.1371\/journal.pone.0220740","article-title":"Comparison of three-fold converted hematocrit and micro-hematocrit in pregnant women.","volume":"14","author":"Kiya","year":"2019","journal-title":"PLoS One"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1080\/14767058.2016.1269166","article-title":"Value of fibrinogen in cases of maternal death related to amniotic fluid embolism.","volume":"30","author":"Tanaka","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R21-20230812","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000077826","article-title":"Amniotic fluid embolism with haemostasis complications: Primary fibrinogenolysis or disseminated intravascular coagulation?.","volume":"33","author":"Biron-Andr\u00e9ani","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1538-7836.2007.02313.x","article-title":"The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: A 5-year overview.","volume":"5","author":"Toh","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/AOG.0000000000001110","article-title":"Disseminated intravascular coagulation syndromes in obstetrics.","volume":"126","author":"Cunningham","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"e93240","DOI":"10.1371\/journal.pone.0093240","article-title":"DIC score in pregnant women\u2013A population based modification of the International Society on Thrombosis and Hemostasis score.","volume":"9","author":"Erez","year":"2014","journal-title":"PLoS One"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/jth.14480","article-title":"Disseminated intravascular coagulation in cardiac arrest and resuscitation.","volume":"17","author":"Gando","year":"2019","journal-title":"J Thromb Haemost"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/CCM.0000000000000217","article-title":"C1 esterase inhibitor activity in amniotic fluid embolism.","volume":"42","author":"Tamura","year":"2014","journal-title":"Crit Care Med"},{"key":"R27-20230812","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.forsciint.2012.12.008","article-title":"Fatal amniotic fluid embolism with typical pathohistological, histochemical and clinical features.","volume":"226","author":"Hikiji","year":"2013","journal-title":"Forensic Sci Int"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/jog.13284","article-title":"Amniotic fluid embolism: Pathophysiology from the perspective of pathology.","volume":"43","author":"Tamura","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial.","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial.","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T09:17:37Z","timestamp":1691831857000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004665","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,7]]}}}